Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genome-wide association study reveals genetic risk factors for trigeminal neuralgia

View ORCID ProfileAndrew T. Hale, Jing He, Oluwatoyin Akinnusotu, Rebecca L. Sale, Janey Wang, Lisa Bastarache, View ORCID ProfileEric R. Gamazon
doi: https://doi.org/10.1101/2021.02.08.21251349
Andrew T. Hale
1Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew T. Hale
  • For correspondence: andrew.hale.1{at}vumc.org
Jing He
2Department of Bioinformatics, Vanderbilt University School of Medicine, Nashville, TN
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oluwatoyin Akinnusotu
3Meharry Medical College, Nashville, TN
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca L. Sale
1Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janey Wang
2Department of Bioinformatics, Vanderbilt University School of Medicine, Nashville, TN
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Bastarache
2Department of Bioinformatics, Vanderbilt University School of Medicine, Nashville, TN
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric R. Gamazon
4Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville TN; Clare Hall & MRC Epidemiology Unit, University of Cambridge (UK)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric R. Gamazon
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background While many clinical risk factors of trigeminal neuralgia (TN) have been identified, the genetic basis of TN is largely unknown. Here, we perform the first genome-wide association study (GWAS) for TN using three independent DNA biobanks – BioVU, the UK Biobank, and Finngen.

Objective To elucidate the genetic basis of TN.

Methods Using GWAS summary statistics generated from BioVU, the UK Biobank, and Finngen, we performed fixed-effect meta-analysis across 490,912 individuals (1,188 TN cases and 489,724 controls) to identify genetic risk factors for TN. Genome-wide significance was defined as p < 5.0×10−8.

Results We identify an intergenic locus on chromosome 1p22.2 flanked by ZNF326 and SNORD3G containing 5 SNPs (rs77449572, rs543311093, rs35117749, rs71666259, and rs116010656) reaching genome-wide significance (p < 5.0 x 10−8), where rs77449572 is the sentinel variant (p = 1.72 x 10−9). The SNP rs77449572 overlaps an enhancer element in cortex-derived neurospheres. In addition, rs71666259 and rs116010656 are located in enhancer elements in embryonic stem cells (HUES48), suggesting potential functional consequences of this locus. We also identify a second locus on chromosome 5q35.1 containing sentinel variant rs62376947 reaching genome-wide significance (p = 2.49 x 10−8).

Conclusions To our knowledge, we perform the first GWAS of TN. Future studies should be aimed at understanding the extent to which genetic variation stratifies response to neuropathic pain medication and whether genetic information may be used to identify patients who are likely to benefit (or not) from surgical intervention.

Competing Interest Statement

Dr. Gamazon receives an honorarium from the journal Circulation Research of the American Heart Association, as a member of the Editorial Board.

Funding Statement

Dr. Hale receives salary support from the National Institutes of Health (NIH, F30HL143826 and R35HG010718). Processing and imputation of genetic data was supported by a grant awarded to Dr. Hale from the Vanderbilt Institute for Clinical and Translational Research (VR53934.1). L.B. is supported by R01LM010685. Dr. Gamazon is supported by the National Human Genome Research Institute of the National Institutes of Health under Award Numbers R35HG010718 and R01HG011138. Dr. Gamazon has also significantly benefitted from a Fellowship at Clare Hall, University of Cambridge (UK) and is grateful to the President and Fellows of the college for a stimulating intellectual home.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional review board approval was provided by Vanderbilt University.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of Interest: Dr. Gamazon receives an honorarium from the journal Circulation Research of the American Heart Association, as a member of the Editorial Board.

  • Disclosure of Funding: Dr. Hale receives salary support from the National Institutes of Health (NIH, F30HL143826 and R35HG010718). Processing and imputation of genetic data was supported by a grant awarded to Dr. Hale from the Vanderbilt Institute for Clinical and Translational Research (VR53934.1). L.B. is supported by R01LM010685. Dr. Gamazon is supported by the National Human Genome Research Institute of the National Institutes of Health under Award Numbers R35HG010718 and R01HG011138. Dr. Gamazon has also significantly benefitted from a Fellowship at Clare Hall, University of Cambridge (UK) and is grateful to the President and Fellows of the college for a stimulating intellectual home.

Data Availability

All data will be made available by the corresponding author, Dr. Andrew Hale (andrew.hale{at}vanderbilt.edu).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 10, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genome-wide association study reveals genetic risk factors for trigeminal neuralgia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genome-wide association study reveals genetic risk factors for trigeminal neuralgia
Andrew T. Hale, Jing He, Oluwatoyin Akinnusotu, Rebecca L. Sale, Janey Wang, Lisa Bastarache, Eric R. Gamazon
medRxiv 2021.02.08.21251349; doi: https://doi.org/10.1101/2021.02.08.21251349
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Genome-wide association study reveals genetic risk factors for trigeminal neuralgia
Andrew T. Hale, Jing He, Oluwatoyin Akinnusotu, Rebecca L. Sale, Janey Wang, Lisa Bastarache, Eric R. Gamazon
medRxiv 2021.02.08.21251349; doi: https://doi.org/10.1101/2021.02.08.21251349

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)